Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
Pinnacle Clinical Research · University of Oxford · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
225
total citations
- FWCI
- 32.79
- Percentile
- 100%
- References
- 38
Citations per year
Authors
19Topics & keywords
Topics
Keywords
- Medicine
- Steatohepatitis
- Placebo
- Clinical endpoint
- Internal medicine
- Fatty liver
- Gastroenterology
- Liver biopsy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.